<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2019-64-5-91-96</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-974</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Эффективность вакцинопрофилактики пневмококковой инфекции и динамика заболеваемости острым средним отитом у детей</article-title><trans-title-group xml:lang="en"><trans-title>The effectiveness of pneumococcal vaccination and dynamics of acute otitis media incidence in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5094-7599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Летифов</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Letifov</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. кафедрой педиатрии с курсом неонатологии,</p><p>344022 Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boiko</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф. кафедры болезней уха, горла, носа,</p><p>344022 Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2894-2062</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стагниева</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stagnieva</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф. кафедры болезней уха, горла, носа,</p><p>344022 Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5620-7228</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукашевич</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukashevich</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры болезней уха, горла, носа,</p><p>344022 Ростов-на-Дону, пер. Нахичеванский, д. 29</p></bio><bio xml:lang="en"><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>15</day><month>11</month><year>2019</year></pub-date><volume>64</volume><issue>5</issue><fpage>91</fpage><lpage>96</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/974">https://www.ped-perinatology.ru/jour/article/view/974</self-uri><abstract><p>Острый средний отит – одна из важнейших проблем детской оториноларингологии. Актуальность ее обусловлена широким распространением заболевания, особенно среди детей младшего возраста, частотой назначения антибактериальной терапии и потенциальной угрозой развития тяжелых осложнений. Наиболее частым возбудителем острого среднего отита является пневмококк. После внедрения в календарь прививок пневмококковой вакцины во многих странах заболеваемость острым средним отитом значительно уменьшилась. Целью исследования был ретроспективный анализ заболеваемости острым средним отитом по данным Ростовской лор-клиники за период с 2012 по 2018 г. Установлен достоверный ежегодный рост числа детей со среднетяжелыми и тяжелыми формами заболевания. В 2018 г. появилась тенденция к снижению доли детей младше 3 лет от общего числа госпитализированных по поводу случаев острого среднего отита, что пока нельзя расценить как результат вакцинации, поскольку заболеваемость острым средним отитом подвержена значительным спонтанным колебаниям и зависит от эпидемиологических особенностей респираторных вирусных инфекций.</p></abstract><trans-abstract xml:lang="en"><p>Acute otitis media is one of the urgent problems of pediatric otolaryngology. Its relevance is predetermined by the wide spread of the disease, especially among young children, the frequency of prescribing antibiotic therapy and the potential threat of severe complications. Pneumococcus is the most frequent causative agent of acute otitis media. Having introduced pneumococcal vaccination the incidence of acute otitis media has significantly decreased in many countries. The aim of the study was a retrospective analysis of the incidence of acute otitis media according to the Rostov ENT clinic for the period from 2012 to 2018. There is a significant annual increase in the number of children with moderate and severe forms of the disease. In 2018 the proportion of children under 3 years hospitalized with acute otitis media tended to reduce, that fact cannot be regarded as a result of vaccination, since the incidence of acute otitis media is subject to significant spontaneous fluctuations and depends on the epidemiological characteristics of viral respiratory infections.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>острый средний отит</kwd><kwd>заболеваемость</kwd><kwd>пневмококковая вакцина</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>acute otitis media</kwd><kwd>prevalence</kwd><kwd>pneumococcal vaccine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Котов Р.В., Рахманова И.В., Шеламова В.Н., Матроскин А.Г., Морозов С.Л., Милева О.И. Варианты патологических изменений полости носа и носоглотки у недоношенных детей в первом полугодии жизни по данным современной эндоскопии. Российский вестник перинатологии и педиатрии 2018; 63(6): 51–54. [Kotov R.V., Rakhmanova I.V., Matroskin A.G., Shelamova V.N., Morozov S.L, Mileva O.I. Modern endoscopy: variants of pathological changes in the nasal cavity and nasopharynx in premature infants during the first six months of life . Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2018; 63(6): 51–54 (in Russ.)] DOI: 10.21508/1027-4065-2018-63-5-51-54</mixed-citation><mixed-citation xml:lang="en">Котов Р.В., Рахманова И.В., Шеламова В.Н., Матроскин А.Г., Морозов С.Л., Милева О.И. Варианты патологических изменений полости носа и носоглотки у недоношенных детей в первом полугодии жизни по данным современной эндоскопии. Российский вестник перинатологии и педиатрии 2018; 63(6): 51–54. [Kotov R.V., Rakhmanova I.V., Matroskin A.G., Shelamova V.N., Morozov S.L, Mileva O.I. Modern endoscopy: variants of pathological changes in the nasal cavity and nasopharynx in premature infants during the first six months of life . Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2018; 63(6): 51–54 (in Russ.)] DOI: 10.21508/1027-4065-2018-63-5-51-54</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Venekamp R.P., Sanders S.L., Glasziou P.P., Del Mar C.B., Rovers M.M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2015; 23–26. DOI: 10.1002/14651858.cd000219.pub4</mixed-citation><mixed-citation xml:lang="en">Venekamp R.P., Sanders S.L., Glasziou P.P., Del Mar C.B., Rovers M.M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2015; 23–26. DOI: 10.1002/14651858.cd000219.pub4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко Н.В. Головокружение в практике врача. Журнал неврологии и психиатрии им. С.С. Корсакова 2005; 105(1): 74–77. [Boiko N.V. Vertigo in medical practice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (S.S. Korsakov Journal of Neurology and Psychiatry) 2005;105(1): 74–77 (in Russ.)]</mixed-citation><mixed-citation xml:lang="en">Бойко Н.В. Головокружение в практике врача. Журнал неврологии и психиатрии им. С.С. Корсакова 2005; 105(1): 74–77. [Boiko N.V. Vertigo in medical practice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (S.S. Korsakov Journal of Neurology and Psychiatry) 2005;105(1): 74–77 (in Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко Н.В., Кунельская Н.Л. Феномен мобильного третьего окна. Вестник оториноларингологии 2016; 81(3): 69–74. Boiko N.V., Kunel’skaya N.L. The phenomenon of mobile third window. Vestnik otorinolaringologii 2016; 81(3): 69–74. (in Russ.). DOI: 10.17116/otorino201681369-74</mixed-citation><mixed-citation xml:lang="en">Бойко Н.В., Кунельская Н.Л. Феномен мобильного третьего окна. Вестник оториноларингологии 2016; 81(3): 69–74. Boiko N.V., Kunel’skaya N.L. The phenomenon of mobile third window. Vestnik otorinolaringologii 2016; 81(3): 69–74. (in Russ.). DOI: 10.17116/otorino201681369-74</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Красножен В.Н., Андреева И.Г., Мамлеев Р.Н., Евдокимова А.Д. Анализ причин развития осложненных форм острого среднего отита у детей. Российский вестник перинатологии и педиатрии 2018; 63(5): 202–206. [Krasnozhen V.N., Andreeva I.G., Mamleev R.N., Evdokimova A.D. Analysis of causes of developing complicated forms of acute otitis media in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2018; 63(5): 202–206. (in Russ.)] DOI: 10.21508/1027-4065-2018-63-5-202-206</mixed-citation><mixed-citation xml:lang="en">Красножен В.Н., Андреева И.Г., Мамлеев Р.Н., Евдокимова А.Д. Анализ причин развития осложненных форм острого среднего отита у детей. Российский вестник перинатологии и педиатрии 2018; 63(5): 202–206. [Krasnozhen V.N., Andreeva I.G., Mamleev R.N., Evdokimova A.D. Analysis of causes of developing complicated forms of acute otitis media in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2018; 63(5): 202–206. (in Russ.)] DOI: 10.21508/1027-4065-2018-63-5-202-206</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McWilliams C.J., Goldman R.D. Update on acute otitis media in children younger than 2 years of age. Canadian Family Physician 2011; 57(11): 1283–1285.</mixed-citation><mixed-citation xml:lang="en">McWilliams C.J., Goldman R.D. Update on acute otitis media in children younger than 2 years of age. Canadian Family Physician 2011; 57(11): 1283–1285.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Usonis V., Jackowska T., Petraitiena S., Sapala A., Neculau A., Stryjewska I. et al. Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC pediatrics 2016; 16(1): 108–116. DOI: 10.1186/s12887-016-0638-2</mixed-citation><mixed-citation xml:lang="en">Usonis V., Jackowska T., Petraitiena S., Sapala A., Neculau A., Stryjewska I. et al. Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC pediatrics 2016; 16(1): 108–116. DOI: 10.1186/s12887-016-0638-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Otsuka T., Kitami O., Kondo K., Ota H., Oshima S. et al. Incidence Survey of Acute Otitis Media in Children in Sado Island, Japan–Sado Otitis Media Study (SADOMS). PLoS ONE 2013; 8(7): e68711. DOI: 10.1371/journal.pone.0068711</mixed-citation><mixed-citation xml:lang="en">Otsuka T., Kitami O., Kondo K., Ota H., Oshima S. et al. Incidence Survey of Acute Otitis Media in Children in Sado Island, Japan–Sado Otitis Media Study (SADOMS). PLoS ONE 2013; 8(7): e68711. DOI: 10.1371/journal.pone.0068711</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Joki-Erkkilä V.P., Laippala P., Pukander J. Increase in paediatric acute otitis media diagnosed by primary care in two Finnish municipalities–1994–5 versus 1978–9. Epidemiol Infect 1998; 121(3): 529–534. DOI: 10.1017/s0950268898001575</mixed-citation><mixed-citation xml:lang="en">Joki-Erkkilä V.P., Laippala P., Pukander J. Increase in paediatric acute otitis media diagnosed by primary care in two Finnish municipalities–1994–5 versus 1978–9. Epidemiol Infect 1998; 121(3): 529–534. DOI: 10.1017/s0950268898001575</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E. et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367(9512): 740–748. DOI: 10.1016/s0140-6736(06)68304-9</mixed-citation><mixed-citation xml:lang="en">Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E. et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367(9512): 740–748. DOI: 10.1016/s0140-6736(06)68304-9</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов Р.С., Муравьев А.А., Щербаков М.Е., Родникова В.Ю., Романенко В.В., Сафьянов К.Н. и др. Исследование распространенности в России острого среднего отита у детей в возрасте от 0 до 5 лет (PAPIRUS-AOM). Клиническая микробиология и антимикробная химиотерапия 2017; 19(2): 116–120. [Kozlov R.S., Muravyev A.A., Scherbakov M.E., Rodnikova V.Yu., Romanenko V.V., Safianov K.N. et al. Study to assess incidence of acute otitis media in children under 5 years of age in Russia (PAPIRUS- AOM). Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(2): 116–120 (in Russ.)]</mixed-citation><mixed-citation xml:lang="en">Козлов Р.С., Муравьев А.А., Щербаков М.Е., Родникова В.Ю., Романенко В.В., Сафьянов К.Н. и др. Исследование распространенности в России острого среднего отита у детей в возрасте от 0 до 5 лет (PAPIRUS-AOM). Клиническая микробиология и антимикробная химиотерапия 2017; 19(2): 116–120. [Kozlov R.S., Muravyev A.A., Scherbakov M.E., Rodnikova V.Yu., Romanenko V.V., Safianov K.N. et al. Study to assess incidence of acute otitis media in children under 5 years of age in Russia (PAPIRUS- AOM). Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya 2017; 19(2): 116–120 (in Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Гуров А.В., Левина Ю.В., Гусева А.Л., Елчуева З.Г., Ефимова С.П., Гордиенко М.В. Микробиологические и клинические особенности острого среднего отита. Вестник оториноларингологии 2018; 83(1): 36–39. [Gurov A.V., Levina Yu.V., Guseva A.L., Elchueva Z.G., Efimova S.P., Gordienko M.V. The specific microbiological and clinical features of acute otitis media. Vestnik otorinolaringologii 2018; 83(1): 36–39 (in Russ.)] DOI: 10.17116/otorino201883136-39</mixed-citation><mixed-citation xml:lang="en">Гуров А.В., Левина Ю.В., Гусева А.Л., Елчуева З.Г., Ефимова С.П., Гордиенко М.В. Микробиологические и клинические особенности острого среднего отита. Вестник оториноларингологии 2018; 83(1): 36–39. [Gurov A.V., Levina Yu.V., Guseva A.L., Elchueva Z.G., Efimova S.P., Gordienko M.V. The specific microbiological and clinical features of acute otitis media. Vestnik otorinolaringologii 2018; 83(1): 36–39 (in Russ.)] DOI: 10.17116/otorino201883136-39</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Протасова И.Н., Домрачева С.В., Волкова О.Ю., Каленский В.А., Перьянова О.В., Веселова О.Ф. и др. Этиологическая роль мультирезистентных Streptococcus pneumonie при остром среднем гнойном отите у детей. Педиатрия. Журнал им. Г.Н. Сперанского 2017; 96(6): 92–98. [Protasova I.N., Domracheva S.V., Volkova O.Yu., Kalenskij V.A., Peryanjva O.V., Velesova O.F. et al. Etiological role of multiresistant Streptococcus pneumoniae in acute purulent otitis media in children. Pediatriya. Zhurnal im. G.N. Speranskogo (Pediatria. Journal named after G.N. Speransky) 2017; 96(6): 92–98 (in Russ.)] DOI: 10.24110/0031-403X-2017-96-6-92-98</mixed-citation><mixed-citation xml:lang="en">Протасова И.Н., Домрачева С.В., Волкова О.Ю., Каленский В.А., Перьянова О.В., Веселова О.Ф. и др. Этиологическая роль мультирезистентных Streptococcus pneumonie при остром среднем гнойном отите у детей. Педиатрия. Журнал им. Г.Н. Сперанского 2017; 96(6): 92–98. [Protasova I.N., Domracheva S.V., Volkova O.Yu., Kalenskij V.A., Peryanjva O.V., Velesova O.F. et al. Etiological role of multiresistant Streptococcus pneumoniae in acute purulent otitis media in children. Pediatriya. Zhurnal im. G.N. Speranskogo (Pediatria. Journal named after G.N. Speransky) 2017; 96(6): 92–98 (in Russ.)] DOI: 10.24110/0031-403X-2017-96-6-92-98</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cattoir V., Merabet L., Legrand P., Soussy C.-J., Leclercq R. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia. J Antimicrob Chemother 2007; 59(5): 1010–1012. DOI: 10.1093/jac/dkm041</mixed-citation><mixed-citation xml:lang="en">Cattoir V., Merabet L., Legrand P., Soussy C.-J., Leclercq R. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia. J Antimicrob Chemother 2007; 59(5): 1010–1012. DOI: 10.1093/jac/dkm041</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor S., Marchisio P., Vergison A., Harriague J., Hausdorff W.P., Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis 2012; 54(12): 1765–73. DOI: 10.1093/cid/cis292</mixed-citation><mixed-citation xml:lang="en">Taylor S., Marchisio P., Vergison A., Harriague J., Hausdorff W.P., Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis 2012; 54(12): 1765–73. DOI: 10.1093/cid/cis292</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения Российской Федерации от 21 марта 2014 г. №125н «О национальном календаре профилактических прививок и календаре профилактических прививок по эпидемическим показаниям». http://legalacts.ru/doc/prikaz-minzdrava- rossii-ot-21032014-n-125n [ Order of the Ministry of Health of the Russian Federation dated March 21, 2014 No.125n «On the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications» (in Russ.)]</mixed-citation><mixed-citation xml:lang="en">Приказ Министерства здравоохранения Российской Федерации от 21 марта 2014 г. №125н «О национальном календаре профилактических прививок и календаре профилактических прививок по эпидемическим показаниям». http://legalacts.ru/doc/prikaz-minzdrava- rossii-ot-21032014-n-125n [ Order of the Ministry of Health of the Russian Federation dated March 21, 2014 No.125n «On the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications» (in Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pneumococcal vaccines. WHO position paper – 2012 – Recommendations. Vaccine. 2012; 30(32): 4717–4718. DOI: 10.1016/j.vaccine.2012.04.093</mixed-citation><mixed-citation xml:lang="en">Pneumococcal vaccines. WHO position paper – 2012 – Recommendations. Vaccine. 2012; 30(32): 4717–4718. DOI: 10.1016/j.vaccine.2012.04.093</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Brooks L.R.K., Mias G.I. Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention. Front Immunol 2018; 9: 1366. DOI: 10.3389/fimmu.2018.01366</mixed-citation><mixed-citation xml:lang="en">Brooks L.R.K., Mias G.I. Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention. Front Immunol 2018; 9: 1366. DOI: 10.3389/fimmu.2018.01366</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Klugman K.P. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Ld Ser B: Biol Sci 2011; 366(1579): 2790–2798. DOI: 10.1098/rstb.2011.0032</mixed-citation><mixed-citation xml:lang="en">Klugman K.P. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Ld Ser B: Biol Sci 2011; 366(1579): 2790–2798. DOI: 10.1098/rstb.2011.0032</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Durando P., Faust S.N., Fletcher M., Krizova P., Torres A., Welte T. Experience with pneumococcal polysaccharide conjugate vaccine ( conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect 2013; 10 (suppl 1): 1–9. DOI: 10.1111/1469-0691.12320</mixed-citation><mixed-citation xml:lang="en">Durando P., Faust S.N., Fletcher M., Krizova P., Torres A., Welte T. Experience with pneumococcal polysaccharide conjugate vaccine ( conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect 2013; 10 (suppl 1): 1–9. DOI: 10.1111/1469-0691.12320</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzwater M.G., Chandran A., Santosham M., Johnson H.L. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012; 31(5): 501–508. DOI: 10.1097/inf.0b013e31824de9f6</mixed-citation><mixed-citation xml:lang="en">Fitzwater M.G., Chandran A., Santosham M., Johnson H.L. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012; 31(5): 501–508. DOI: 10.1097/inf.0b013e31824de9f6</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kyaw M., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A. et al. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae. N Engl J Med 2006; 354(14): 1455–1463. DOI: 10.1056/nejmoa051642</mixed-citation><mixed-citation xml:lang="en">Kyaw M., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A. et al. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae. N Engl J Med 2006; 354(14): 1455–1463. DOI: 10.1056/nejmoa051642</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lucero M.G., Dulalia V.E., Nillos L.T., Williams G., Parreño R.A., Nohynek H., Riley I.D., Makela H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009; 4: CD004977. DOI: 10.1002/14651858.cd004977.pub2</mixed-citation><mixed-citation xml:lang="en">Lucero M.G., Dulalia V.E., Nillos L.T., Williams G., Parreño R.A., Nohynek H., Riley I.D., Makela H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009; 4: CD004977. DOI: 10.1002/14651858.cd004977.pub2</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Amare A.T., Kebede Z.T., Welch H.D. Epidemiology of bacterial meningitis in children admitted to Gondar University Hospital in the post pneumococcal vaccine era. Pan Afr Med J 2018; 31: 193. DOI: 10.11604/pamj.2018.31.193.10254</mixed-citation><mixed-citation xml:lang="en">Amare A.T., Kebede Z.T., Welch H.D. Epidemiology of bacterial meningitis in children admitted to Gondar University Hospital in the post pneumococcal vaccine era. Pan Afr Med J 2018; 31: 193. DOI: 10.11604/pamj.2018.31.193.10254</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lindstrand A., Bennet R., Galanis I., Blennow M., Ask L.S., Dennison S.H. et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics 2014; 134(6): 1528–1536. DOI: 10.1542/peds.2013-4177</mixed-citation><mixed-citation xml:lang="en">Lindstrand A., Bennet R., Galanis I., Blennow M., Ask L.S., Dennison S.H. et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics 2014; 134(6): 1528–1536. DOI: 10.1542/peds.2013-4177</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lau W.C.Y., Bielicki J., Tersigni C., Saxena S., Wong I.C.K., Sharland M., Hsia Y. All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study. Pharmacoepidemiol Drug Saf 2019. DOI: 10.1002/pds.4770</mixed-citation><mixed-citation xml:lang="en">Lau W.C.Y., Bielicki J., Tersigni C., Saxena S., Wong I.C.K., Sharland M., Hsia Y. All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study. Pharmacoepidemiol Drug Saf 2019. DOI: 10.1002/pds.4770</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Koelman D.L.H., Brouwer M.C., van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect 2019. DOI: 10.1016/j.cmi.2019.04.032</mixed-citation><mixed-citation xml:lang="en">Koelman D.L.H., Brouwer M.C., van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect 2019. DOI: 10.1016/j.cmi.2019.04.032</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kim L., McGee L., Tomczyk S., Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States Perspective. Clin Microbiol Rev 2016; 29(3): 525–552. DOI: 10.1128/cmr.00058-15</mixed-citation><mixed-citation xml:lang="en">Kim L., McGee L., Tomczyk S., Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States Perspective. Clin Microbiol Rev 2016; 29(3): 525–552. DOI: 10.1128/cmr.00058-15</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Setchanova L., Alexandrova A., Pencheva D., Sirakov I., Mihova K., Kaneva R., Mitov I. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria. J Glob Antimicrob Resist 2018; 15: 6–11. DOI: 10.1016/j.jgar.2018.05.012</mixed-citation><mixed-citation xml:lang="en">Setchanova L., Alexandrova A., Pencheva D., Sirakov I., Mihova K., Kaneva R., Mitov I. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria. J Glob Antimicrob Resist 2018; 15: 6–11. DOI: 10.1016/j.jgar.2018.05.012</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X., de Luise C., Gaffney M., Burt C.W., Scott D.A., Gatto N., Center K.J. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States. Int J Pediatr Otorhinolaryngol 2019; 119: 96–102. DOI: 10.1016/j.ijporl.2019.01.023</mixed-citation><mixed-citation xml:lang="en">Zhou X., de Luise C., Gaffney M., Burt C.W., Scott D.A., Gatto N., Center K.J. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States. Int J Pediatr Otorhinolaryngol 2019; 119: 96–102. DOI: 10.1016/j.ijporl.2019.01.023</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Littorin N., Ahl J., Udden F., Resman F., Riesbeck K. Reduction of Streprococcus pneumoniae in upper tract cultures and a decreases incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in Swedish country. BMC Infect Dis 2016; 16(1): 407. DOI: 10.1186/s12879-016-1750-5</mixed-citation><mixed-citation xml:lang="en">Littorin N., Ahl J., Udden F., Resman F., Riesbeck K. Reduction of Streprococcus pneumoniae in upper tract cultures and a decreases incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in Swedish country. BMC Infect Dis 2016; 16(1): 407. DOI: 10.1186/s12879-016-1750-5</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Fortanier A., Venekamp R.P., Hoes A.W., Schilder A.G.M. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study. Vaccine 2019; 37(11): 1528–1532. DOI: 10.1016/j.vaccine.2019.01.064</mixed-citation><mixed-citation xml:lang="en">Fortanier A., Venekamp R.P., Hoes A.W., Schilder A.G.M. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study. Vaccine 2019; 37(11): 1528–1532. DOI: 10.1016/j.vaccine.2019.01.064</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ziv O., Kraus M., Holcberg R., Dinur A.B., Kordeluk S., Kaplan D., et al. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 2019; 119: 123–130. DOI: 10.1016/j.ijporl.2019.01.031</mixed-citation><mixed-citation xml:lang="en">Ziv O., Kraus M., Holcberg R., Dinur A.B., Kordeluk S., Kaplan D., et al. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 2019; 119: 123–130. DOI: 10.1016/j.ijporl.2019.01.031</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
